Screening strategies for active tuberculosis: Focus on cost-effectiveness

ClinicoEconomics and Outcomes Research

Volumn 8, Issue , 2016, Pages 335-347

  Dobler, Claudia Caroline ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Active case finding; Disease elimination; Epidemic; Review

Indexed keywords

COMMUNITY CARE; COST EFFECTIVENESS ANALYSIS; DISABILITY ADJUSTED LIFE YEAR; HIGH RISK POPULATION; HUMAN; INCIDENCE; MASS RADIOGRAPHY; OUTCOME ASSESSMENT; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW; SCREENING TEST; THORAX RADIOGRAPHY; TUBERCULOSIS;

EID: 84988980059     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S92244     Document Type: Review

References (72)

1. World Health Organization. Global Tuberculosis Report 2014. Geneva: WHO; 2014.
2. World Health Organization. Global strategy and targets for tuberculosis prevention, care and control after 2015. 2014. Available from: http:// www.who.int/tb/post2015_strategy/en. Accessed May 25, 2016.
3. Pinet G. Good Practice in Legislation and Regulations for TB Control: An Indicator of Political Will. Geneva: WHO; 2001.
4. Abebe M, Doherty M, Wassie L, et al. TB case detection: can we remain passive while the process is active? Pan Afr Med J. 2012;11: 50.
5. Dowdy DW, Chaisson RE. The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection. Bull World Health Organ. 2009;87(4): 296-304.
6. Dudley SF. Pulmonary tuberculosis in the Royal Navy and the use of mass miniature radiography in its control. Proc R Soc Med. 1941;34(7): 401-406.
7. Wayburn E. Mass miniature radiography; a survey in the United States Army Air Forces. Am Rev Tuberc. 1946;54(6): 527-540.
8. Dick WP. Mass miniature radiography of factory groups. Br Med J. 1945;2(4425): 568-569.
9. Bynum H. Spitting Blood: The History of Tuberculosis. Oxford: Oxford University Press; 2012.
10. Raviglione MC, Pio A. Evolution of WHO policies for tuberculosis control, 1948-2001. Lancet. 2002;359(9308): 775-780.
11. Golub JE, Mohan CI, Comstock GW, Chaisson RE. Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis. 2005;9(11): 1183-1203.
12. Banerji D, Andersen S. A sociological study of awareness of symptoms among persons with pulmonary tuberculosis. Bull World Health Organ. 1963;29(5): 665-683.
13. Baily GV, Savic D, Gothi GD, Naidu VB, Nair SS. Potential yield of pulmonary tuberculosis cases by direct microscopy of sputum in a district of south India. Bull World Health Organ. 1967;37(6): 875-892.
14. [No authors listed]. Tuberculosis baseline survey in Burma in 1972. Tubercle. 1974;55(4): 313-325.
15. Santha T, Garg R, Subramani R, et al. Comparison of cough of 2 and 3 weeks to improve detection of smear-positive tuberculosis cases among out-patients in India. Int J Tuberc Lung Dis. 2005;9(1): 61-68.
16. Stýblo K, Danková D, Drápela J, et al. Epidemiological and clinical study of tuberculosis in the district of Kolin, Czechoslovakia: report for the first 4 years of the study (1961-64). Bull World Health Organ. 1967;37(6): 819-874.
17. Krivinka R, Drápela J, Kubík A, et al. Epidemiological and clinical study of tuberculosis in the district of Kolin, Czechoslovakia: second report (1965-1972). Bull World Health Organ. 1974;51(1): 59-69.
18. Stýblo K. Epidemiology of Tuberculosis. 2nd ed. The Hague: Royal Netherlands Tuberculosis Association (KNCV); 1991.
19. Toman K. Mass radiography in tuberculosis control. WHO Chron. 1976;30(2): 51-57.
20. World Health Organization. WHO Expert Committee on Tuberculosis: Ninth Report. Geneva: WHO; 1974.
21. Kranzer K, Afnan-Holmes H, Tomlin K, et al. The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review. Int J Tuberc Lung Dis. 2013;17(4): 432-446.
22. Shapiro A, Golub JE. Systematic review of number needed to screen (NNS) in selected risk groups with different screening approaches. Poster presented at: Scoping Meeting for the Development of Guidelines on Screening for Active TB; 31 May-1 June 2011; Geneva, Switzerland.
23. Shargie EB, Mørkve O, Lindtjørn B. Tuberculosis case-f inding through a village outreach programme in a rural setting in southern Ethiopia: community randomized trial. Bull World Health Organ. 2006;84(2): 112-119.
24. Datiko DG, Lindtjørn B. Health extension workers improve tuberculosis case detection and treatment success in southern Ethiopia: a community randomized trial. PLoS One. 2009;4(5): e5443.
25. Moyo S, Verver S, Hawkridge A, et al. Tuberculosis case finding for vaccine trials in young children in high-incidence settings: a randomised trial. Int J Tuberc Lung Dis. 2012;16(2): 185-191.
26. Miller AC, Golub JE, Cavalcante SC, et al. Controlled trial of active tuberculosis case finding in a Brazilian favela. Int J Tuberc Lung Dis. 2010;14(6): 720-726.
27. Corbett EL, Bandason T, Duong T, et al. Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial. Lancet. 2010;376(9748): 1244-1253.
28. Okada K, Onozaki I, Yamada N, et al. Epidemiological impact of mass tuberculosis screening: a 2-year follow-up after a national prevalence survey. Int J Tuberc Lung Dis. 2012;16(12): 1619-1624.
29. Cavalcante SC, Durovni B, Barnes GL, et al. Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis. 2010;14(2): 203-209.
30. Rendleman NJ. Mandated tuberculosis screening in a community of homeless people. Am J Prev Med. 1999;17(2): 108-113.
31. Ayles H, Muyoyeta M, Du Toit E, et al. Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial. Lancet. 2013;382(9899): 1183-1194.
32. World Health Organization. Systematic Screening for Active Tuberculosis: Principles and Recommendations. Geneva: WHO; 2013.
33. Fox GJ, Dobler CC, Marks GB. Active case finding in contacts of people with tuberculosis. Cochrane Database Syst Rev. 2011;(9): CD008477.
34. Shah L, Rojas M, Mori O, et al. Implementation of a stepped-wedge cluster randomized design in routine public health practice: design and application for a tuberculosis (TB) household contact study in a high burden area of Lima, Peru. BMC Public Health. 2015;15: 587.
35. Fox GJ, Nhung NV, Sy DN, Britton WJ, Marks GB. Household contact investigation for tuberculosis in Vietnam: study protocol for a cluster randomized controlled trial. Trials. 2013;14: 342.
36. Banoo S, Bell D, Bossuyt P, et al. Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol. 2006;4(12 Suppl): S20-S32.
37. Pai M, Minion J, Sohn H, Zwerling A, Perkins MD. Novel and improved technologies for tuberculosis diagnosis: progress and challenges. Clin Chest Med. 2009;30(4): 701-716, viii.
38. Steingart KR, Ramsay A, Pai M. Optimizing sputum smear microscopy for the diagnosis of pulmonary tuberculosis. Expert Rev Anti Infect Ther. 2007;5(3): 327-331.
39. Nicol MP, Zar HJ. New specimens and laboratory diagnostics for childhood pulmonary TB: progress and prospects. Paediatr Respir Rev. 2011;12(1): 16-21.
40. Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis. 2009;9(3): 173-184.
41. Rawat J, Biswas D, Sindhwani G, Kesharwani V, Masih V, Chauhan BS. Diagnostic defaulters: an overlooked aspect in the Indian Revised National Tuberculosis Control Program. J Infect Dev Ctries. 2012;6(1): 20-22.
42. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377(9776): 1495-1505.
43. Singh KK, Muralidhar M, Kumar A, et al. Comparison of in house polymerase chain reaction with conventional techniques for the detection of Mycobacterium tuberculosis DNA in granulomatous lymphadenopathy. J Clin Pathol. 2000;53(5): 355-361.
44. Pai M, Schito M. Tuberculosis diagnostics in 2015: landscape, priorities, needs, and prospects. J Infect Dis. 2015;211(Suppl 2): S21-S28.
45. Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;1: CD009593.
46. World Health Organization. WHO monitoring of Xpert MTB/RIF roll-out. 2013. Available from: http://www.who.int/tb/areas-of-work/ laboratory/mtb-rif-rollout/en. Accessed May 26, 2016.
47. UNITAID. Tuberculosis: Diagnostics Technology and Market Landscape. 3rd ed. Geneva: World Health Organization; 2014.
48. Pai M. Innovations in tuberculosis diagnostics: progress and translational challenges. EBioMedicine. 2015;2(3): 182-183.
49. [No authors listed]. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis. 1990;142(3): 725-735.
50. Pai M, Rodrigues C. Management of latent tuberculosis infection: an evidence-based approach. Lung India. 2015;32(3): 205-207.
51. Pai M, Gokhale K, Joshi R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon γ assay with tuberculin skin testing. JAMA. 2005;293(22): 2746-2755.
52. World Health Organization. The Global Burden of Disease concept. Available from: http://www.who.int/quantifying_ehimpacts/publications/ en/9241546204chap3.pdf. Accessed March 13, 2016.
53. Tan Torres T, Baltussen R, Adam T, et al, editors. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva: World Health Organization; 2003. Available from: http://www.who.int/choice/publications/ p_2003_generalised_cea.pdf. Accessed March 13, 2016.
54. World Health Organization. Macroeconomics and Health: Investing in Health for Economic Development. Geneva: WHO; 2001.
55. Hutubessy R, Chisholm D, Edejer TT. Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc. 2003;1(1): 1-13.
56. Sekandi JN, Dobbin K, Oloya J, Okwera A, Whalen CC, Corso PS. Costeffectiveness analysis of community active case finding and household contact investigation for tuberculosis case detection in urban Africa. PLoS One. 2015;10(2): e0117009.
57. Azman AS, Golub JE, Dowdy DW. How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India. BMC Med. 2014;12: 216.
58. Mupere E, Schiltz NK, Mulogo E, Katamba A, Nabbuye-Sekandi J, Singer ME. Effectiveness of active case-finding strategies in tuberculosis control in Kampala, Uganda. Int J Tuberc Lung Dis. 2013;17(2): 207-213.
59. Harper I, Fryatt R, White A. Tuberculosis case finding in remote mountainous areas: are microscopy camps of any value? Experience from Nepal. Tuber Lung Dis. 1996;77(4): 384-388.
60. Yadav RP, Nishikiori N, Satha P, Eang MT, Lubell Y. Cost-effectiveness of a tuberculosis active case finding program targeting household and neighborhood contacts in Cambodia. Am J Trop Med Hyg. 2014;90(5): 866-872.
61. Dasgupta K, Schwartzman K, Marchand R, Tennenbaum TN, Brassard P, Menzies D. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med. 2000;162(6): 2079-2086.
62. Zwerling AA, Sahu M, Ngwira LG, et al. Screening for tuberculosis among adults newly diagnosed with HIV in sub-Saharan Africa: a cost-effectiveness analysis. J Acquir Immune Defic Syndr. 2015;70(1): 83-90.
63. Andrews JR, Lawn SD, Rusu C, et al. The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS. 2012;26(8): 987-995.
64. Wingate LT, Coleman MS, Posey DL, et al. Cost-effectiveness of screening and treating foreign-born students for tuberculosis before entering the United States. PLoS One. 2015;10(4): e0124116.
65. Feingold AO. Cost effectiveness of screening for tuberculosis in a general medical clinic. Public Health Rep. 1975;90(6): 544-547.
66. Kranzer K, Lawn SD, Meyer-Rath G, et al. Feasibility, yield, and cost of active tuberculosis case finding linked to a mobile HIV service in Cape Town, South Africa: a cross-sectional study. PLoS Med. 2012;9(8): e1001281.
67. Winetsky DE, Negoescu DM, DeMarchis EH, et al. Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis. PLoS Med. 2012;9(11): e1001348.
68. Jones TF, Schaffner W. Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis. Am J Respir Crit Care Med. 2001;164(1): 77-81.
69. Kowada A. Cost effectiveness of interferon-gamma release assay for tuberculosis screening of rheumatoid arthritis patients prior to initiation of tumor necrosis factor-α antagonist therapy. Mol Diagn Ther. 2010;14(6): 367-373.
70. Kowada A, Deshpande GA, Takahashi O, Shimbo T, Fukui T. Cost effectiveness of interferon-gamma release assay versus chest X-ray for tuberculosis screening of BCG-vaccinated elderly populations. Mol Diagn Ther. 2010;14(4): 229-236.
71. Kowada A. Cost-effectiveness of interferon-γ release assay versus chest X-ray for tuberculosis screening of employees. Am J Infect Control. 2011;39(10): e67-e72.
72. Sekandi JN, Neuhauser D, Smyth K, Whalen CC. Active case finding of undetected tuberculosis among chronic coughers in a slum setting in Kampala, Uganda. Int J Tuberc Lung Dis. 2009;13(4): 508-513.